SUMMARY:

Radionuclide generator systems continue to play a key role in providing both diagnostic and therapeutic radionuclides for various applications in nuclear medicine, oncology and interventional cardiology. Although many parent/daughter pairs have been evaluated as radionuclide generator systems, there is a relatively small number of generators which are currently in routine clinical and research use. Essentially every conceivable approach has been used for parent/separation strategies, including sublimation, thermochromatographic separation, solvent extraction and adsorptive column chromatography. The most widely used radionuclide generator for clinical applications is the ⁹⁹Mo/ ^99mTc generator system, but recent years have seen an enormous increase in the use of generators to provide therapeutic radionuclides, which has paralleled the development of complementary technologies for targeting agents for therapy and in the general increased interest in the use of unsealed therapeutic radioactive sources. Key advantages for the use of radionuclide generators include reasonable costs, the convenience of obtaining the desired daughter radionuclide on demand, and availability of the daughter radionuclide in high specific activity, no-carrier added form.

1. INTRODUCTION